Sir,
Protein-losing gastroenteropathy (PLGE) is a disease in which proteins are lost through the gastrointestinal tract. Possible mechanisms of PLGE have been classified as follows: mucosal erosion/ ulceration, intestinal lymphangiectasia and increased mucosal capillary permeability. 1 Systemic lupus erythematosus (SLE) can be complicated by PLGE. 2, 3 The pathophysiology of PLGE associated with SLE (SLE-PLGE) remains uncertain, although previous reports have suggested that the mechanism may involve gastrointestinal inflammatory processes. 4, 5 The pathophysiology of Me´ne´trier's disease, which is defined as idiopathic PLGE, is associated with increased signalling through the epidermal growth factor receptor (EGFR) by transforming growth factor-alpha (TGF-a) and vascular endothelial growth factor (VEGF). 6 Whether TGF-a and VEGF are involved in SLE-PLGE has not been reported. We experienced a case of SLE-PLGE accompanied by high serum levels of TGF-a and VEGF.
A 33-year-old woman developed systemic oedema. Arthritis, lymphopaenia, a high titre of antinuclear antibodies and positivity for anti-Sm were found. Thus, the patient was diagnosed with SLE. On admission, the serum levels of albumin were decreased to 1.7 g/dl. Cardiac, hepatic and renal functions were normal. Skin rash, serositis, nephritis and neuropsychiatric lupus were not revealed. Upper endoscopy revealed the appearance of giant mucosal folds (Figure 1(a) ). Scintigraphy showed protein loss from the stomach and upper small intestine. Therefore, we diagnosed the patient with SLE-PLGE. Her oedema improved within a few days after high-dose corticosteroid was administered. The serum levels of albumin were increased to 3.6 g/dl. The gastric giant folds disappeared after treatment.
To clarify the mechanism of SLE-PLGE in this case, serum TGF-a (R&D systems, Minneapolis, MN, USA) and VEGF (Mitsubishi Chemical Medience, Japan) were measured by ELISA. We obtained blood samples both on admission and on the 45th day after treatment. Compared with other 20 SLE patients who were not complicated with PLGE, the serum TGF-a were higher in the present case at 88.1 pg/ml (median value: 6.1 pg/ml in those 20 SLE patients) and VEGF was 106 pg/ml (normal value: <38.3 pg/ml). After treatment with corticosteroids, the serum TGF-a and VEGF decreased to 29.6 pg/ml and 43.7 pg/ml, respectively.
In Me´ne´trier's disease, the expressions of TGF-a and EGFR are increased in the parietal cells. 7 TGFa is a ligand of EGFR. Activated EGFR signalling due to local overproduction of TGF-a is involved in the pathophysiology of Me´ne´trier's disease. 8 Moreover, TGF-a stimulates the expression of VEGF mRNA in T-lymphocytes and macrophages. 6 VEGF plays a key role in protein leakage from blood vessels. In this case, the interstitium of the gastric glands was oedematous (Figure 1(b) ). Inflammatory cells such as CD8 þ cells and CD68 þ cells (Figure 1(c, d) ) were scattered throughout the mucosal interstitium. Immunohistochemical stainings of TGF-a and EGFR were found in the fundic glands ( Figure 1(e, f) ). We speculated that upregulation of TGF-a/EGFR signalling and production of VEGF by T-lymphocytes and macrophages in the gastrointestinal tract were involved in the pathophysiology of SLE-PLGE.
In SLE-PLGE, TGF-a and VEGF may be potential biomarkers and treatment targets, although a large number of patients should be examined.
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